Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Colorectal cancer (CRC) is a major cause of cancer-related mortality, with metastases typically involving the liver and lungs. Solitary bone metastasis to the ankle is exceedingly rare and presents significant diagnostic challenges.

Case Presentation: A 46-year-old male presented with constipation, abdominal pain, and persistent right foot discomfort following a previous talus fracture that failed to heal with conservative management. Imaging studies revealed a sigmoid colon mass and a Solitary lesion in the right talus. Biopsy of the colon and ankle specimens confirmed poorly differentiated signet ring cell adenocarcinoma. The patient was treated with a chemotherapy regimen and palliative radiotherapy which led to improved performance status.

Clinical Discussion: Colon and rectum have different patterns of metastasis due to different vasculature and anatomy. Although metastatic bone lesions can be seen in both of them, talus bone involvement has been rarely reported. Non-specific skeletal-related events should be taken into consideration as they can be primary symptoms of bone metastasis or even the first symptoms that lead to CRC diagnosis.

Conclusion: This case highlights a rare solitary metastatic pathway of CRC and underscores the importance of a comprehensive diagnostic work-up in patients with treatment-refractory bone disorders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12246623PMC
http://dx.doi.org/10.1016/j.ijscr.2025.111515DOI Listing

Publication Analysis

Top Keywords

bone metastasis
8
bone
5
solitary
4
solitary metastases
4
colon
4
metastases colon
4
colon adenocarcinoma
4
adenocarcinoma ankle
4
ankle case
4
case report
4

Similar Publications

Osteosarcoma (OS), the most prevalent primary bone malignancy in adolescents, is characterized by aggressive progression and early metastasis. However, the epigenetic drivers of its metastatic heterogeneity remain poorly understood. Herein, we integrated bulk DNA methylation profiling and single-cell RNA sequencing (scRNA-seq) to elucidate the epigenetic mechanisms driving OS metastatic heterogeneity.

View Article and Find Full Text PDF

The microstructure of metastatic bone lesions suggests tumor mediated alterations in bone mineralization.

Bone

September 2025

Department of Mechanical Engineering, Texas A&M University, 3123 TAMU, College Station, TX, 77843, United States of America; School of Engineering Medicine, Texas A&M University, 1020 Holcombe Blvd, Houston, TX 77030, United States of America. Electronic address:

Breast, prostate and lung cancer cells frequently metastasize to bone, leading to disruption of the bone microstructure. This study utilized mechanical testing with micro-CT imaging, digital volume correlation (DVC), and atomic force microscopy (AFM) nanomechanical testing to examine the mechanical property variations in mouse long bones (tibia) with metastatic lung cancer cell involvement, spanning from the whole-bone scale to the microstructural level. In addition, we also investigated how metastatic invasion alters the morphology of hydroxyapatite nanocrystals in bone at the nanometer scale.

View Article and Find Full Text PDF

Recent years have seen the development and advent of novel combinatorial strategies based on immunotherapy, and immune checkpoint inhibitor (ICI) - based treatment has established itself as a mainstay in the treatment of metastatic urothelial carcinoma (UC). Herein, we aimed to validate the prognostic value of a previously developed score, the Prognostic Immunotherapy Score (PIS), including female sex, Eastern Cooperative Oncology Group Performance Status (ECOG-PS) and liver metastases, in patients treated with pembrolizumab for advanced UC from the ARON-2 dataset. We retrospectively analyzed clinical data from Metastatic UC patients diagnosed at age ≥ 18 years.

View Article and Find Full Text PDF

Hyaluronic acid and polyvinyl alcohol-based radioresponsive hydrogel for combined radioimmunotherapy of breast cancer bone metastasis.

Carbohydr Polym

November 2025

State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China. Electronic address:

Combining radiotherapy with immunotherapy holds promise for treating solid tumors and metastases, but challenges persist, including hypoxia-induced immunosuppression and immune-related adverse events from off-target toxicity. To address this, we engineered an in-situ formed hydrogel by crosslinking hyaluronic acid and polyvinyl alcohol with a reactive oxygen species (ROS)-responsive linker (3-aminophenylboronic acid). This hydrogel leverages radiotherapy-induced ROS within the tumor microenvironment to trigger localized release of nitric oxide (NO) and the toll-like receptor 7/8 (TLR7/8) agonist R848.

View Article and Find Full Text PDF

A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era.

Eur J Cancer

September 2025

Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Aim Of The Study: The aim of the study is to describe clinical features, treatment approach and outcomes of recurrent/metastatic (R/M) NPC in non-endemic areas MATERIALS AND METHODS: This observational, retrospective and multicenter study was conducted within 36 referral hospital in non-endemic areas including Europe, Jordan, Kuwait, Turkey and United States of America. All NPC patients diagnosed between 2004 and 2016 and with a minimum 12 months of follow-up were included. Data entry started in January 2018 and closed in December 2023.

View Article and Find Full Text PDF